{
    "id": "625144c9e764a53204000016",
    "question": "Is neurofilament light marker for disease?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents and understand the role of neurofilaments in the human body and their relationship to disease. Neurofilaments are a type of intermediate filament protein that plays a crucial role in providing structural support and strength to neurons. They are composed of three main types: NF-L, NF-M, and NF-H. These proteins coassemble to form heteropolymers that extend from the cell body into the axon and dendrites. The overexpression of human NF-L or NF-H in mice results in mice that have an ALS-like disease, but a causative link between neurofilament pathology and ALS has not been firmly established. However, neurofilaments are involved in the pathogenesis of certain neurodegenerative diseases. For example, in Alzheimer's disease, neurofilaments are composed of abnormally phosphorylated tau protein, which can lead to neurofibrillary tangles. Similarly, in amyotrophic lateral sclerosis (ALS), neurofilaments are affected early in the illness, and the overexpression of human NF-L or NF-H in mice results in mice that have an ALS-like disease. Furthermore, neurofilaments are also involved in other diseases such as frontotemporal dementia (FTD) and chronic traumatic encephalopathy (CTE). In FTD, neurofilaments are characterized by the presence of tau or TDP-43 inclusions, while in CTE, neurofilaments are composed of abnormally phosphorylated tau protein. Based on this information, we can conclude that neurofilaments are not a marker for disease, but rather they are involved in the pathogenesis of certain neurodegenerative diseases. However, the neurofilament light chain (NF-L) is a marker for certain neurodegenerative diseases, such as ALS and FTD. Therefore, the correct answer is B. no, neurofilaments are not a marker for disease, but NF-L is a marker for certain diseases.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Cell_Biology_Alberts_4721",
            "title": "Cell_Biology_Alberts",
            "content": "The neurodegenerative disease amyotrophic lateral sclerosis (ALS, or Lou Gehrig\u2019s disease) is associated with an accumulation and abnormal assembly of neurofilaments in motor neuron cell bodies and in the axon, aberrations that may interfere with normal axonal transport. The degeneration of the axons leads to muscle weakness and atrophy, which is usually fatal. The overexpression of human NF-L or NF-H in mice results in mice that have an ALS-like disease. However, a causative link between neurofilament pathology and ALS has not been firmly established. basal cell of epidermis"
        },
        {
            "id": "Pathology_Robbins_65",
            "title": "Pathology_Robbins",
            "content": "Neurofilaments: Axons of neurons, imparting strength and rigidity Glial fibrillary acidic protein: Glial cells that support neurons Cytokeratins: Epithelial cells express more than 30 distinct varieties with distinct patterns of expression in different lineages (e.g., lung versus gastrointestinal epithelia). These can serve as histochemical markers for various epithelia Intermediate filaments are found predominantly in a ropelike polymerized form and primarily serve to impart tensile strength and allow cells to bear mechanical stress. The nuclear membrane lamins are important not only for maintaining nuclear morphology but also for regulating nuclear gene transcription. The critical roles of lamins is emphasized by rare but fascinating disorders caused by lamin mutations, which range from certain forms of muscular dystrophy to progeria, a disease of premature aging. Intermediate filaments also form the major structural proteins of epidermis and hair."
        },
        {
            "id": "Cell_Biology_Alberts_4726",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 16\u201370 Two types of intermediate filaments in cells of the nervous system. Freeze-etch electron microscopic image of neurofilaments in a nerve cell axon, showing the extensive cross-linking through protein cross-bridges\u2014an arrangement believed to give this long cell process great tensile strength. The cross-bridges are formed by the long, nonhelical extensions at the C-terminus of the largest neurofilament protein (NF-H). (B) Freeze-etch image of glial filaments in glial cells, showing that these intermediate filaments are smooth and have few cross-bridges. Conventional transmission electron micrograph of a cross section of an axon showing the regular side-to-side spacing of the neurofilaments, which greatly outnumber the microtubules. (A and B, courtesy of Nobutaka Hirokawa; C, courtesy of John Hopkins.)"
        },
        {
            "id": "Cell_Biology_Alberts_4719",
            "title": "Cell_Biology_Alberts",
            "content": "Members of another family of intermediate filaments, called neurofilaments, are found in high concentrations along the axons of vertebrate neurons (Figure 16\u201370). Three types of neurofilament proteins (NF-L, NF-M, and NF-H) coassemble in vivo, forming heteropolymers. The NF-H and NF-M proteins have lengthy C-terminal tail domains that bind to neighboring filaments, generating aligned arrays with a uniform interfilament spacing. During axonal growth, new neurofilament subunits are incorporated all along the axon in a dynamic process that involves the addition of subunits along the filament length as well as the ends. After an axon has grown and connected with its target cell, the diameter of the axon may increase as much as fivefold. The level of neurofilament gene expression seems to directly control axonal diameter, which in turn influences how fast electrical signals travel down the axon. In addition, neurofilaments provide strength and stability to the long cell processes of"
        },
        {
            "id": "Neurology_Adams_8471",
            "title": "Neurology_Adams",
            "content": "Three additional microscopic changes give this disease its distinctive character: (1) The presence within the nerve cell cytoplasm of thick, fiber-like strands of silver-staining material, also in the form of loops, coils, or tangled masses (Alzheimer neurofibrillary changes or \u201ctangles\u201d) (Fig. 38-1). These strands are composed of a hyperphosphorylated form of the microtubular protein, tau, and appear as pairs of helical filaments when studied ultrastructurally. (2) Spherical deposits of amorphous material scattered throughout the cerebral cortex and easily seen with periodic acid-Schiff (PAS); the core of the aggregates is the protein amyloid, surrounded by degenerating nerve terminals (neuritic plaques) that stains with silver. Amyloid is also scattered throughout the cerebral cortex in a nascent \u201cdiffuse\u201d form, without organization or core formation and then is appreciated mainly by immunohistochemical methods, as well as deposition in the walls of small blood vessels near the"
        },
        {
            "id": "InternalMed_Harrison_30544",
            "title": "InternalMed_Harrison",
            "content": "In each of these diseases, the affected motor neurons undergo shrinkage, often with accumulation of the pigmented lipid (lipofuscin) that normally develops in these cells with advancing age. In ALS, the motor neuron cytoskeleton is typically affected early in the illness. Focal enlargements are frequent in proximal motor axons; ultrastructurally, these \u201cspheroids\u201d are composed of accumulations of neurofilaments and other proteins. Commonly in both sporadic and familial Upper and lower motor neuron Amyotrophic lateral sclerosis Predominantly upper motor neuron Primary lateral sclerosis Predominantly lower motor neuron Multifocal motor neuropathy with Motor neuropathy with paraprotein Associated with other neurodegenerative disorders"
        },
        {
            "id": "Neurology_Adams_8479",
            "title": "Neurology_Adams",
            "content": "stabilizes their structure, and participates in synaptic plasticity in a yet to be defined manner. In the pathologic circumstances of Alzheimer disease, progressive supranuclear palsy, and one form of frontotemporal dementia (see further on), tau is hyperphosphorylated and aggregates, resulting in paired helical filaments that make up the neurofibrillary tangles. Electrophoretically, tau moves with the \u03b22-globulins and functions as a transferrin, that is, it binds iron and delivers it to the cell. Its concentration can be measured in the CSF and serum, but this has not yet proven clearly to be useful as a diagnostic test or to offer understanding of the pathogenesis of the disease."
        },
        {
            "id": "Histology_Ross_346",
            "title": "Histology_Ross",
            "content": "\u0081 Class 4. Historically this group has been called neuroflaments; they contain intermediate filament proteins that are expressed mostly in axons of nerve cells. The three types of neurofilament proteins are of different molecular weights: NF-L (a low-weight protein), NF-M (a medium-weight protein), and NF-H (a high-weight protein). They co-assemble to form a heterodimer that contains one NF-L molecule and one of the others. All three proteins form neurofilaments that extend from the cell body into the ends of axons and dendrites, providing structural support. However, genes for class 4 proteins also encode several other intermediate filament proteins. These include nestin and -internexin in nerve cells as well as synemin, syncoilin, and paranemin in muscle cells. Members of this group preferentially co-assemble in tissues as heteropolymers."
        },
        {
            "id": "InternalMed_Harrison_30547",
            "title": "InternalMed_Harrison",
            "content": "and brainstem to the lateral and anterior white matter columns of the spinal cord. The loss of fibers in the lateral columns and resulting fibrillary gliosis impart a particular firmness (lateral sclerosis). A remarkable feature of the disease is the selectivity of neuronal cell death. By light microscopy, the entire sensory apparatus, the regulatory mechanisms for the control and coordination of movement, remains intact. Except in cases of frontotemporal dementia, the components of the brain required for cognitive processing are also preserved. However, immunostaining indicates that neurons bearing ubiquitin, a marker for degeneration, are also detected in nonmotor systems. Moreover, studies of glucose metabolism in the illness also indicate that there is neuronal dysfunction outside of the motor system. Within the motor system, there is some selectivity of involvement. Thus, motor neurons required for ocular motility remain unaffected, as do the parasympathetic neurons in the sacral"
        },
        {
            "id": "Pathology_Robbins_64",
            "title": "Pathology_Robbins",
            "content": "Intermediate filaments are fibrils 10-nm in diameter that comprise a large and heterogeneous family. Members include lamins A, B, and C, which contribute to the structure of nuclear lamina. Individual types of intermediate filaments have characteristic tissue-specific patterns of expression that are useful for identifying the cellular origin of poorly differentiated tumors. Vimentin: Mesenchymal cells (fibroblasts, endothelium) anchoring intracellular organelles Desmin: Muscle cells, forming the scaffold on which actin and myosin contract Neurofilaments: Axons of neurons, imparting strength and rigidity Glial fibrillary acidic protein: Glial cells that support neurons"
        },
        {
            "id": "Cell_Biology_Alberts_4720",
            "title": "Cell_Biology_Alberts",
            "content": "directly control axonal diameter, which in turn influences how fast electrical signals travel down the axon. In addition, neurofilaments provide strength and stability to the long cell processes of neurons."
        },
        {
            "id": "Histology_Ross_1727",
            "title": "Histology_Ross",
            "content": "of flattened sacs and vesicles. Other characteristic organelles include mitochondria (M) and lysosomes (L). The neurofilaments and neurotubules are difficult to discern at this relatively low magnification. 15,000."
        },
        {
            "id": "Histology_Ross_350",
            "title": "Histology_Ross",
            "content": "cells (mainly astrocytes; (GFAP) to lesser degree, ependymal cells), Schwann cells, enteric glial cells, satellite cells of sensory ganglia, and pituicytes Peripherin 54 Peripheral neurons Class 4: Neurofilaments Neuroflament L (NF-L) 68 Neurons Charcot-Marie-tooth disease Co-assembles with NF-M or NF-H Parkinson disease Neuroflament M (NF-M) 110 Neurons Co-assembles with NF-L Neuroflament H (NF-H) 130 Neurons Co-assembles with NF-L Nestin 240 Neural stem cells, some cells of neuroectodermal origin, muscle cells Co-assembles with desmin \u0391-Internexin 68 Neurons Synemin \u0391/\u0392A 182 Muscle cells Co-assembles with desmin Syncoilin 64 Muscle cells Paranemin 178 Muscle cells Co-assembles with desmin Class 5: Lamins Lamin A/CB 62\u201372 Nucleus of all nucleated cells Emery-Dreyfuss muscular dystrophy Lamin B 65\u201368 Nucleus of all nucleated cells Limb girdle muscular dystrophy Class 6: Beaded Filaments Phakinin (CP49)C 49 Eye lens fber cells Juvenile-onset cataracts Co-assembles with flesin"
        },
        {
            "id": "Neurology_Adams_10692",
            "title": "Neurology_Adams",
            "content": "depopulated of nerve fibers, the amount of congophilic staining and the characteristic amyloid birefringence may be meager and yield a spuriously negative result. It is also critical to ensure the accuracy of congophilic staining by comparison with positive and negative control tissue from the same laboratory. The CSF has a normal or mildly elevated protein concentration, but this does not distinguish the neuropathic process from many others."
        },
        {
            "id": "Neurology_Adams_8478",
            "title": "Neurology_Adams",
            "content": "Analyses of the plaques and neuronal fibrillary changes have been undertaken in an attempt to elucidate the mechanism of Alzheimer disease, but so far, to little avail beyond implicating one or both in the accompanying neuronal degeneration. Several histologic techniques assist in this endeavor, including refined methods for silver impregnation that stain both amyloid and its main constituent (beta-amyloid protein [A\u03b2]); immunostaining using antibodies specific to such proteins as ubiquitin, neuronal tau protein, and \u03b2-amyloid protein; and visualization of \u03b2-pleated protein sheets using thioflavine S and in the past especially, Congo red with ultraviolet and polarized light. Tau (composed chemically of \u03b22-transferrin) is a discrete cytoskeletal protein that promotes the assembly of microtubules, stabilizes their structure, and participates in synaptic plasticity in a yet to be defined manner. In the pathologic circumstances of Alzheimer disease, progressive supranuclear palsy, and one"
        },
        {
            "id": "First_Aid_Step1_549",
            "title": "First_Aid_Step1",
            "content": "Taste\u2014CN VII, IX, X (solitary nucleus). Pain\u2014CN V3, IX, X. Motor\u2014CN X, XII. The Genie comes out of the lamp in style. Neurons Signal-transmitting cells of the nervous system. Permanent cells\u2014do not divide in adulthood. Signal-relaying cells with dendrites (receive input), cell bodies, and axons (send output). Cell bodies and dendrites can be seen on Nissl staining (stains RER). RER is not present in the axon. Neuron markers: neurofilament protein, synaptophysin. Astrocytes Most common glial cell type in CNS. Physical Derived from neuroectoderm. support, repair, extracellular K+ buffer, removal Astrocyte marker: GFAP. of excess neurotransmitter, component of blood-brain barrier, glycogen fuel reserve buffer. Reactive gliosis in response to neural injury."
        },
        {
            "id": "InternalMed_Harrison_30258",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 448-5 Neuropathology in frontotemporal lobar degeneration (FTLD). FTLD-tau (A\u2013C) and FTLD-TDP (D\u2013F) account for over 90% of patients with FTLD, and immunohistochemistry reveals characteristic lesions in each of the major histopathologic subtypes within each class: small compact or crescentic neuronal cytoplasmic inclusions and short, then neuropil threads in FTLD-TDP, type A; (E) diffuse/granular neuronal cytoplasmic inclusions (with a relative paucity of neuropil threads) in FTLD-TDP, type B; and (F) long, tortuous dystrophic neurites in FTLD-TDP, type C. TDP can be seen within the nucleus in neurons lacking inclusions but mislocalizes to the cytoplasm and forms inclusions in FTLD-TDP. Immunostains are 3-repeat tau (A), phospho-tau (B and C), and TDP-43 (D\u2013F). Sections are counterstained with hematoxylin. Scale bar applies to all panels and represents 50 \u03bcm in A, B, C, and E and 100 \u03bcm in D and F."
        },
        {
            "id": "Histology_Ross_349",
            "title": "Histology_Ross",
            "content": "TABLE Classes of Intermediate Filaments Their Location and Associated Diseases 2.3 Molecular Weight Examples of Type of Protein (kDa) Where Found Associated Diseases Class 1 and 2: Keratins Acid cytokeratins 40\u201364 All epithelial cells Epidermolysis bullosa simplex Basic cytokeratins 52\u201368 All epithelial cells Keratoderma disorders caused by keratin mutations Meesman corneal dystrophy Class 3: Vimentin and Vimentin-like Vimentin 55 Cells of mesenchymal origin Desmin-related myopathy (including endothelial cells, (DRM) myofbroblasts, some smooth Dilated cardiomyopathy muscle cells) and some cells of Alexander disease neuroectodermal origin Amyotrophic lateral sclerosis Desmin 53 Muscle cells; co-assembles with (ALS) nestin, synemin and paranemin Glial fbrillary acidic protein 50\u201352 Neuroglial cells (mainly astrocytes; (GFAP) to lesser degree, ependymal cells), Schwann cells, enteric glial cells, satellite cells of sensory ganglia, and pituicytes Peripherin 54 Peripheral neurons Class 4:"
        },
        {
            "id": "InternalMed_Harrison_30266",
            "title": "InternalMed_Harrison",
            "content": "substantia nigra, amygdala, cingulate gyrus, and, ultimately, the neocortex. Lewy bodies are intraneuronal cytoplasmic inclusions that stain with periodic acid\u2013Schiff (PAS) and ubiquitin but are now identified with antibodies to the presynaptic protein, \u03b1-synuclein. Lewy bodies are composed of straight neurofilaments 7\u201320 nm long with surrounding amorphous material and contain epitopes recognized by antibodies against phosphorylated and nonphosphorylated neurofilament proteins, ubiquitin, and \u03b1-synuclein. Lewy bodies are typically found in the substantia nigra of patients with idiopathic PD, where they can be readily seen with hematoxylin-and-eosin staining. A profound cholinergic deficit, owing to basal forebrain and pedunculopontine nucleus involvement, is present in many patients with DLB and may be a factor responsible for the fluctuations, inattention, and visual hallucinations. Due to the frequent comorbidity with AD and the cholinergic deficit in DLB, cholinesterase inhibitors"
        },
        {
            "id": "Histology_Ross_1723",
            "title": "Histology_Ross",
            "content": "perinuclear Golgi apparatus, lysosomes, microtubules, neurofilaments (intermediate filaments), transport vesicles, and inclusions (Fig. 12.4b). Nissl bodies, free ribosomes, and occasionally the Golgi apparatus extend into the dendrites but not into the axon. This area of the cell body, called the axon hillock, lacks large cytoplasmic organelles and serves as a landmark to distinguish between axons and dendrites in both light microscope and TEM preparations. The euchromatic nucleus, large nucleolus, prominent Golgi apparatus, and Nissl bodies indicate the high level of anabolic activity needed to maintain these large cells. Neurons do not divide; however, in some areas of the brain, neural stem cells are present and are able to differentiate and replace damaged nerve cells."
        },
        {
            "id": "Neurology_Adams_8413",
            "title": "Neurology_Adams",
            "content": "It has been proposed that all degenerative diseases be classified according to their genetic and molecular abnormalities. However, when one notes the diversity of pathologic change that may accompany a single, seemingly unitary gene abnormality or, reciprocally, the diversity of genetic defects that may underlie a single phenotype, this type of classification does not prove immediately helpful to the clinician. In other words, the practice of creating new disease categories to encompass all the molecular and pathologic changes associated with a particular type of neuronal degeneration offers no great advantage in practice. For example, certain diseases are unified by the deposition of proteins and have been termed \u201ctauopathies,\u201d \u201csynucleinopathies,\u201d \u201camyloidopathies,\u201d and so forth. We endorse a more useful clinical approach that is based on an awareness of constellations of clinical features that relate to degeneration of specific neural systems. Until such time as the causation of"
        },
        {
            "id": "InternalMed_Harrison_30247",
            "title": "InternalMed_Harrison",
            "content": "Although early studies suggested that 15\u201330% of patients with FTD showed underlying AD at autopsy, progressive refinement in clinical diagnosis has improved pathologic prediction accuracy, and most patients diagnosed with FTD at a dementia clinic with expertise in FTD will show underlying FTLD pathology. Microscopic findings seen across all patients with FTLD include gliosis, microvacuolation, and neuronal loss, but the disease is subtyped according to the protein composition of neuronal and glial inclusions, which contain either tau or TDP-43 in ~90% of patients, with the remaining ~10% showing inclusions containing FUS (Fig. 448-4)."
        },
        {
            "id": "Neurology_Adams_10684",
            "title": "Neurology_Adams",
            "content": "malignant plasma cell dyscrasia. This agrees with our own experience, but other series have found rates of myeloma as high as 75 percent. In any case, 90 percent of primary amyloidosis is the result of a monoclonal protein in the blood (rarely polyclonal). Macrophage enzymes cleave the larger immunoglobulin molecules and the light chains aggregate to form amyloid deposits in tissue, or the plasma cells may produce light chains directly (\u201clight chain disease\u201d). Lambda light chain predominates in the idiopathic variety of amyloidosis and kappa light chain is more common in myeloma. In a few cases, the light chain is found only in the urine (as Bence Jones protein)."
        },
        {
            "id": "Histology_Ross_370",
            "title": "Histology_Ross",
            "content": "Actin flaments are essential for various stages of leukocyte in neuroflaments within brain tissue are characteristic of migration as well as for the phagocytotic functions of vari Alzheimer\u2019s disease, which produces neurofbrillary ous cells. Some chemical substances isolated from fungi, tangles containing neuroflaments and other microtubule such as cytochalasin B and cytochalasin D, prevent associated proteins."
        },
        {
            "id": "Neurology_Adams_8521",
            "title": "Neurology_Adams",
            "content": "the symptoms of dementia and parkinsonism are related to neurofibrillary changes in the cerebral cortex and substantia nigra, respectively; senile plaques and Lewy bodies are unusual findings. What can be deduced from the crossover syndromes is that multiple degenerative changes can occur in these diseases and give rise to heterogeneity in clinical presentation."
        },
        {
            "id": "InternalMed_Harrison_30252",
            "title": "InternalMed_Harrison",
            "content": "Although the term Pick\u2019s disease was once used to describe a progressive degenerative disorder characterized by selective involvement of the anterior frontal and temporal neocortex and pathologically by intraneuronal cytoplasmic inclusions (Pick bodies), it is now used only in reference to a specific FTLD-tau histopathologic entity. Classical Pick bodies are argyrophilic, staining positively with the Bielschowsky silver method (but not with the Gallyas method) and also with immunostaining for hyperphosphorylated tau. Recognition of the three FTLD major molecular classes has allowed delineation of distinct FTLD subtypes within each class. These subtypes, based on the morphology and distribution of the neuronal and glial inclusions (Fig. 448-5), account for the vast majority of patients, and some subtypes show strong clinical or genetic associations (Fig. 448-4). Despite this progress, available data do not allow reliable prediction of the underlying FTLD subtype, or even the major"
        },
        {
            "id": "Neurology_Adams_7321",
            "title": "Neurology_Adams",
            "content": "Chap. 2). These tests had been used with greater frequency in the past and have been largely supplanted by MRI to detect dispersed demyelinating lesions. Optical coherence tomography (OCT) is a technique that measures the back-scattering of near-infrared light to create extremely high resolution cross-sectional images of the optic nerve and retina. Automatic segmentation of the retinal nerve fiber layer thickness allows accurate, reliable quantification of axonal loss and thinning over time that follows optic neuritis. The association of anti-aquaporin 4 (anti-AQP4) antibodies and myelin oligodendrocyte glycoprotein antibodies (anti-MOG) in Devic disease acute disseminated encephalomyelitis will be discussed further on."
        },
        {
            "id": "Histology_Ross_1797",
            "title": "Histology_Ross",
            "content": "\u0081 Fibrous astrocytes are more common in the inner core of the brain called white matter. These astrocytes have fewer processes, and they are relatively straight (Fig. 12.18). Both types of astrocytes contain prominent bundles of intermediate filaments composed of glial fbrillary acidic protein (GFAP). The filaments are much more numerous in"
        },
        {
            "id": "InternalMed_Harrison_30249",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 448-4 Frontotemporal dementia syndromes are united by underlying frontotemporal lobar degeneration pathology, which can be divided according to the presence of tau, TPD-43, or FUS-containing inclusions in neurons and glia. Correlations between clinical syndromes and major molecular classes are shown with colored shading. Despite improvements in clinical syndromic diagnosis, a small percentage of patients with some frontotemporal dementia syndromes will show Alzheimer\u2019s disease neuropathology at autopsy (gray shading). aFTLD-U, atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions; AGD, argyrophilic grain disease; BIBD, basophilic inclusion body disease; bvFTD, behavioral variant frontotemporal dementia; CBD, corticobasal degeneration; CBS, corticobasal syndrome; CTE, chronic traumatic encephalopathy; FTD-MND, frontotemporal dementia with motor neuron disease; FTDP-17, frontotemporal dementia with parkinsonism linked to chromosome 17; FUS, fused in"
        },
        {
            "id": "InternalMed_Harrison_31164",
            "title": "InternalMed_Harrison",
            "content": "Disulfiram Accumulation of neurofila-Numbness, tingling, and burn-Axonal degeneration with Low-amplitude or unobtainable ments and impaired axoplas-ing pain in a length-dependent accumulation of neurofila-SNAPs with normal or reduced mic flow pattern ments in the axons CMAP amplitudes Dapsone Unknown Distal weakness that may progress Axonal degeneration and seg-Low-amplitude or unobtainable to proximal muscles; sensory loss mental demyelination CMAPs with normal or reduced SNAP amplitudes SNAPs with normal or reduced CMAP amplitudes Nitrofurantoin Unknown Numbness, painful paresthesias, Axonal degeneration; autopsy Low-amplitude or unobtainable and severe weakness that may studies reveal degeneration SNAPs with normal or reduced resemble GBS of dorsal root ganglia and CMAP amplitudes anterior horn cells Pyridoxine Unknown Dysesthesias and sensory ataxia; Marked loss of sensory axons Reduced amplitudes or absent (vitamin B6)"
        },
        {
            "id": "Neurology_Adams_8731",
            "title": "Neurology_Adams",
            "content": "Many types of inclusions are, of course, nonspecific, as, for example, \u03b1-synuclein\u2013positive inclusions have been detected in several neurodegenerative syndromes. Appropriate control studies to determine whether the glial inclusions are found in nondegenerative lesions in brain (e.g., at the edge of an infarct) are needed. Also lacking is information about the frequency of these cytoplasmic inclusions in relation to the aging brain."
        },
        {
            "id": "InternalMed_Harrison_30211",
            "title": "InternalMed_Harrison",
            "content": "function of the A\u03b2 peptides remains uncertain. APP has neurotrophic and neuroprotective properties. The plaque core is surrounded by a halo, which contains dystrophic, tau-immunoreactive neurites and activated microglia. The accumulation of A\u03b2 in cerebral arterioles is termed amyloid angiopathy. NFTs are composed of silver-staining neuronal cytoplasmic fibrils composed of abnormally phosphorylated tau protein; they appear as paired helical filaments by electron microscopy. Tau binds to and stabilizes microtubules, supporting axonal transport of organelles, glycoproteins, neurotransmitters, and other important cargoes throughout the neuron. Once hyperphosphorylated, tau can no longer bind properly to microtubules and redistributes from the axon to throughout the neuronal cytoplasm and distal dendrites, compromising function. Finally, patients with AD often show comorbid DLB or vascular pathology. In animal models of AD, diminishing neuronal tau ameliorates the cognitive deficits and"
        }
    ],
    "scores": [
        0.028208311606618165,
        0.027990950985580958,
        0.02760788311247027,
        0.026831787535991962,
        0.026427230793267212,
        0.02496805520061334,
        0.02458454717015702,
        0.024303311068016954,
        0.02355438299350748,
        0.023073959938366716,
        0.02224481066200855,
        0.022162532096306933,
        0.02194177965001711,
        0.021111404367630156,
        0.018219461697722567,
        0.01647058823529412,
        0.016437992974083646,
        0.016330513988288872,
        0.015919959728165116,
        0.015763076188201577,
        0.015390965915791957,
        0.015325895478567234,
        0.0148380355276907,
        0.01470276008492569,
        0.014112416026291624,
        0.014097744360902255,
        0.014059514059514059,
        0.013867842218854756,
        0.013714285714285714,
        0.013461538461538462,
        0.013371290545203588,
        0.012792574656981436
    ]
}